Xtant Medical Holdings (XTNT) Net Cash Flow Growth (3y) (2013 - 2025)
Xtant Medical Holdings (XTNT) Net Cash Flow Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -9.45% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 60.16% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -85.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 43.26% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -26.30% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 21.48% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -127.77% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 269.22% |
| 10 | Xtant Medical Holdings | 46.53 Mn | 28.93 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 66.98% |
| Jun 30, 2025 | 147.02% |
| Mar 31, 2025 | 17.89% |
| Dec 31, 2024 | -49.34% |
| Sep 30, 2024 | 41.44% |
| Jun 30, 2024 | -22.82% |
| Mar 31, 2024 | -27.58% |
| Dec 31, 2023 | -93.61% |
| Sep 30, 2023 | 160.42% |
| Jun 30, 2023 | -63.52% |
| Mar 31, 2023 | -96.23% |
| Dec 31, 2022 | 97.23% |
| Sep 30, 2022 | 35.39% |
| Jun 30, 2022 | -36.82% |
| Mar 31, 2022 | -88.71% |
| Dec 31, 2021 | -28.68% |
| Sep 30, 2021 | -24.77% |
| Jun 30, 2021 | 158.72% |
| Mar 31, 2021 | 70.04% |
| Dec 31, 2020 | -35.87% |